Adelaide, March 15, 2020: (ACN Newswire) - Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has expanded its lab…
NEW DELHI, NOVEMBER-07-2019: The US Food and Drug Administration (FDA) has approved Sandoz’ biosimilar Ziextenzo (pegfilgrastim-bmez). The biosimilar pegfilgrastim has been…
Data Includes Additional Analyses of Long-Term Extension Phase 1b Study With Titration Cohort at 36 Months and Fixed-Dose Cohorts at…